Erratum to "Cardiovascular Drugs for the Newborn" [Clin Perinatol 32 (4) (2005) 979-997] (DOI:10.1016/j.clp.2005.09.013);Cardiovascular drugs for the newborn

Clinics in Perinatology

Volumn 32, Issue 4, 2005, Pages 979-997

  Ward, Robert M ^a   Lugo, Ralph A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; AMRINONE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATROPINE; BICARBONATE; CALCIUM CHLORIDE; CARDIOVASCULAR AGENT; DIGOXIN; DISOPYRAMIDE; ESMOLOL; FLECAINIDE; GLUCONATE CALCIUM; INOTROPIC AGENT; LIDOCAINE; MEXILETINE; MILRINONE; MORACIZINE; NALOXONE; OUABAIN; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANTIARRHYTHMIC ACTIVITY; BONE DISEASE; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CHOREOATHETOSIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORNEA DISEASE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG URINE LEVEL; FIRST PASS EFFECT; FORWARD HEART FAILURE; GROWTH DISORDER; HEADACHE; HEART ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTENSION; HYPOTHYROIDISM; LIVER CLEARANCE; LIVER DYSFUNCTION; LUNG INFILTRATE; NEWBORN CARE; OBESITY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY ARREST; RESUSCITATION; REVIEW; SEIZURE; SIDE EFFECT; SINUS BRADYCARDIA; SINUS TACHYCARDIA; SKIN COLOR; SLEEP DISORDER; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; WHEEZING;

EID: 28444445632     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2006.03.014     Document Type: Erratum

References (126)

1. A.O. Grant Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination Pacing Clin Electrophysiol 20 2 Pt 2 1997 432 444
2. J.C. Perry Pharmacologic therapy of arrhythmias B.J. Deal G. Wolff H. Gelband Current concepts in diagnosis and management of arrhythmias in infants and children 1998 Futura Publishing Co., Inc. Armonk, (NY) 267 305
3. E.M. Vaughan Williams Classification of antiarrhythmic drugs E. Sandoe E. Flensted-Jensen E.H. Olsen Symposium on cardiac arrhythmias 1970 Astra Denmark 449 501
4. M.-L. Young, B.J. Deal, and G.S. Wolff Supraventricular tachycardia-electrophysiologic evaluation and treatment B.J. Deal G. Wolff H. Gelband Current concepts in diagnosis and management of arrhythmias in infants and children 1998 Futura Publishing Co., Inc Armonk (NY) 145 179
5. R.J. Roberts Drug therapy in infants. pharmacologic principles and clinical experience 1984 WB Saunders Company Philadelphia
6. American Academy of Pediatrics Committee on Drugs Drugs for pediatric emergencies Pediatrics 10 1998 e13
7. B.J. Deal Supraventricular tachycardia mechanisms and natural history B.J. Deal G. Wolff H. Gelband Current concepts in diagnosis and management of arrhythmias in infants and children 1998 Futura Publishing Co., Inc. Armonk (NY) 117 143
8. A.M. Cilliers, J.P. du Plessis, and S.A. Clur Junctional ectopic tachycardia in six paediatric patients Heart 78 4 1997 413 415
9. A. Garson Jr, and P.C. Gillette Junctional ectopic tachycardia in children: electrocardiography, electrophysiology and pharmacologic response Am J Cardiol 44 2 1979 298 302
10. A. Ludomirsky, and A. Garson Jr Supraventricular tachycardia P.C. Gillette A. Garson Jr Pediatric arrhythmias: electrophysiology and pacing 1990 WB Saunders Philadelphia 380 426
11. J.P. Pfammatter, and F.P. Stocker Re-entrant supraventricular tachycardia in infancy: current role of prophylactic digoxin treatment Eur J Pediatr 157 2 1998 101 106
12. S.A. Luedtke, R.J. Kuhn, and F.M. McCaffrey Pharmacologic management of supraventricular tachycardias in children. Part 2: atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia Ann Pharmacother 31 11 1997 1347 1359
13. G. Paret, D. Steinmetz, and J. Kuint Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants Am J Perinatol 13 6 1996 343 346
14. P. Smits, J.W. Lenders, and T. Thien Caffeine and theophylline attenuate adenosine-induced vasodilation in humans Clin Pharmacol Ther 48 4 1990 410 418
15. C.I. Berul Higher adenosine dosage required for supraventricular tachycardia in infants treated with theophylline Clin Pediatr (Phila) 32 3 1993 167 168
16. J.P. Moak Pharmacology and electrophysiology of antiarrhythmic drugs P.C. Gillette A. Garson Jr Pediatric arrhythmias: electrophysiology and pacing 1990 WB Saunders Philadelphia 37 115
17. M.M. Reidenberg, D.E. Drayer, and M. Levy Polymorphic acetylation procainamide in man Clin Pharmacol Ther 17 6 1975 722 730
18. J.S. Leeder, and G.L. Kearns Pharmacogenetics in pediatrics. Implications for practice Pediatr Clin North Am 44 1 1997 55 77
19. M.S. Lemler, and M.S. Schaffer Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal Am Heart J 133 1 1997 130 131
20. C.J. Byrum, R.A. Wahl, and D.M. Behrendt Ventricular fibrillation associated with use of digitalis in a newborn infant with Wolff-Parkinson-White syndrome J Pediatr 101 3 1982 400 403
21. A.S. Nies, and D.G. Shand Clinical pharmacology of propranolol Circulation 52 1 1975 6 15
22. M.L. Epstein, E.A. Kiel, and B.E. Victorica Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia Pediatrics 75 4 1985 737 740
23. J.W. Mason Amiodarone N Engl J Med 316 8 1987 455 466
24. I. Kodama, K. Kamiya, and J. Toyama Cellular electropharmacology of amiodarone Cardiovasc Res 35 1 1997 13 29
25. J. Ardura, F. Hermoso, and J. Bermejo Effect on growth of children with cardiac dysrhythmias treated with amiodarone Pediatr Cardiol 9 1 1988 33 36
26. B.R. Keeton, C.A. Bucknall, and P.V. Curry Use of amiodarone in childhood Br J Clin Pract Suppl 44 1986 115 120
27. C.J. Daniels, D.A. Schutte, and S. Hammond Acute pulmonary toxicity in an infant from intravenous amiodarone Am J Cardiol 80 8 1997 1113 1116
28. J.C. Perry, A.L. Fenrich, and J.E. Hulse Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol J Am Coll Cardiol 27 5 1996 1246 1250
29. H. Dodo, R.M. Gow, and R.M. Hamilton Chaotic atrial rhythm in children Am Heart J 129 5 1995 990 995
30. F.A. Fish, A.V. Mehta, and J.A. Johns Characteristics and management of chaotic atrial tachycardia of infancy Am J Cardiol 78 9 1996 1052 1055
31. T. Bouillon, H. Schiffmann, and D. Bartmus Amiodarone in a newborn with ventricular tachycardia and an intracardiac tumor: adjusting the dose according to an individualized dosing regimen Pediatr Cardiol 17 2 1996 112 114
32. R.P. Chen, A.P. Ignaszewski, and M.A. Robertson Successful treatment of supraventricular tachycardia-induced cardiomyopathy with amiodarone: case report and review of literature Can J Cardiol 11 10 1995 918 922
33. E.M. Rosenberg, F. Elbl, and R.E. Solinger Neonatal refractory supraventricular tachycardia: successful treatment with amiodarone South Med J 81 4 1988 539 540
34. S. Burri, M.I. Hug, and U. Bauersfeld Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants Eur J Pediatr 162 12 2003 880 884
35. A.L. Fenrich Jr, J.C. Perry, and R.A. Friedman Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy J Am Coll Cardiol 25 5 1995 1195 1198
36. S.P. Etheridge, J.E. Craig, and S.J. Compton Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants Am Heart J 141 1 2001 105 110
37. R. Kannan, S.M. Yabek, and A. Garson Jr Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels Am Heart J 114 2 1987 283 287
38. T.R. Vrobel, P.E. Miller, and N.D. Mostow A general overview of amiodarone toxicity: its prevention, detection, and management Prog Cardiovasc Dis 31 6 1989 393 426
39. D. De Wolf, J. De Schepper, and H. Verhaaren Congenital hypothyroid goiter and amiodarone Acta Paediatr Scand 77 4 1988 616 618
40. M. Laurent, P. Betremieux, and Y. Biron Neonatal hypothyroidism after treatment by amiodarone during pregnancy Am J Cardiol 60 10 1987 942
41. L.A. Magee, E. Downar, and M. Sermer Pregnancy outcome after gestational exposure to amiodarone in Canada Am J Obstet Gynecol 172 4 Pt 1 1995 1307 1311
42. R. Tubman, J. Jenkins, and J. Lim Neonatal hyperthyroxinaemia associated with maternal amiodarone therapy: case report Ir J Med Sci 157 7 1988 243
43. A.B. Zubrow, S. Hulman, and H. Kushner Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group J Perinatol 15 6 1995 470 479
44. J.T. Flynn Neonatal hypertension: diagnosis and management Pediatr Nephrol 14 4 2000 332 341
45. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents Pediatrics 114 2004 555 576
46. D.B. Wiest, S.S. Garner, and W.E. Uber Esmolol for the management of pediatric hypertension after cardiac operations J Thorac Cardiovasc Surg 115 4 1998 890 897
47. C. Milou, V. Debuche-Benouachkou, and D.S. Semama Intravenous nicardipine as a first-line antihypertensive drug in neonates Intensive Care Med 26 7 2000 956 958
48. J.B. Gouyon, B. Geneste, and D.S. Semama Intravenous nicardipine in hypertensive preterm infants Arch Dis Child Fetal Neonatal Ed 76 2 1997 F126 F127
49. T.G. Wells, T.E. Bunchman, and G.L. Kearns Treatment of neonatal hypertension with enalaprilat J Pediatr 117 4 1990 664 667
50. S.B. Bauer, S.M. Feldman, and S.S. Gellis Neonatal hypertension. a complication of umbilical-artery catheterization N Engl J Med 293 20 1975 1032 1033
51. M.C. Nahata, R.S. Morosco, and T.F. Hipple Stability of captopril in three liquid dosage forms Am J Hosp Pharm 51 1 1994 95 96
52. R.F. O'Dea, B.L. Mirkin, and C.T. Alward Treatment of neonatal hypertension with captopril J Pediatr 113 2 1988 403 406
53. J.A. Romankiewicz, R.N. Brogden, and R.C. Heel Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure Drugs 25 1 1983 6 40
54. L.M. Strauser, T. Groshong, and J.D. Tobias Initial experience with isradipine for the treatment of hypertension in children South Med J 93 3 2000 287 293
55. D.J. Driscoll Use of inotropic and chronotropic agents in neonates Clin Perinatol 14 4 1987 931 949
56. B.B. Hoffman Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists J.G. Hardman L.E. Limbird A.G. Gilman Goodman & Gilman's the pharmacological basis of therapeutics 10th edition 2001 McGraw-Hill New York 215 268
57. A. Zaritsky, and B. Chernow Use of catecholamines in pediatrics J Pediatr 105 3 1984 341 350
58. B.B. Hoffman, and P. Taylor Neurotransmission: The autonomic and somatic motor nervous systems J.G. Hardman L.E. Limbird A.G. Gilman Goodman and Gilman's the pharmacological basis of therapeutics 10th edition 2001 McGraw Hill New York 115 153
59. R.E. Rude, L.R. Bush, and C. Izquierdo Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. III. Influence of basal heart rate Am J Cardiol 53 11 1984 1688 1694
60. M. Heckmann, A. Trotter, and F. Pohlandt Epinephrine treatment of hypotension in very low birthweight infants Acta Paediatr 91 5 2002 566 570
61. B.K. Siwy, and A.M. Sadove Acute management of dopamine infiltration injury with Regitine Plast Reconstr Surg 80 4 1987 610 612
62. I. Seri, T. Tulassay, and J. Kiszel Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease Eur J Pediatr 142 1 1984 3 9
63. D.J. Driscoll, P.C. Gillette, and R.M. Lewis Comparative hemodynamic effects of isoproterenol, dopamine, and dobutamine in the newborn dog Pediatr Res 13 9 1979 1006 1009
64. D.H. Fiser, J.E. Fewell, and D.E. Hill Cardiovascular and renal effects of dopamine and dobutamine in healthy, conscious piglets Crit Care Med 16 4 1988 340 345
65. C.A. Perez, J.M. Reimer, and M.D. Schreiber Effect of high-dose dopamine on urine output in newborn infants Crit Care Med 14 12 1986 1045 1049
66. I. Seri, S. Abbasi, and D.C. Wood Regional hemodynamic effects of dopamine in the sick preterm neonate J Pediatr 133 6 1998 728 734
67. J.M. Liet, C. Boscher, and C. Gras-Leguen Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus J Pediatr 140 3 2002 373 375
68. R.R. Tuttle, and J. Mills Dobutamine: development of a new catecholamine to selectively increase cardiac contractility Circ Res 36 1 1975 185 196
69. R.R. Ruffolo Jr, and E.L. Yaden Vascular effects of the stereoisomers of dobutamine J Pharmacol Exp Ther 224 1 1983 46 50
70. A.M. Martinez, J.F. Padbury, and S. Thio Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates Pediatrics 89 1 1992 47 51
71. J.C. Roze, C. Tohier, and C. Maingueneau Response to dobutamine and dopamine in the hypotensive very preterm infant Arch Dis Child 69 1 Spec No 1993 59 63
72. A. Greenough, and E.F. Emery Randomized trial comparing dopamine and dobutamine in preterm infants Eur J Pediatr 152 11 1993 925 927
73. J.M. Klarr, R.G. Faix, and C.J. Pryce Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome J Pediatr 125 1 1994 117 122
74. D. Osborn, N. Evans, and M. Kluckow Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow J Pediatr 140 2 2002 183 191
75. T.M. Hoffman, G. Wernovsky, and A.M. Atz Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 107 7 2003 996 1002
76. A. Ward, R.N. Brogden, and R.C. Heel Amrinone. a preliminary review of its pharmacological properties and therapeutic use Drugs 26 6 1983 468 502
77. G.D. Williams, G.K. Sorensen, and R. Oakes Amrinone loading during cardiopulmonary bypass in neonates, infants, and children J Cardiothorac Vasc Anesth 9 3 1995 278 282
78. J.M. Bailey, B.E. Miller, and K.R. Kanter A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery Anesth Analg 84 2 1997 294 298
79. P. Laitinen, J.M. Happonen, and H. Sairanen Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect J Cardiothorac Vasc Anesth 11 7 1997 870 874
80. P. Laitinen, J.M. Happonen, and H. Sairanen Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries J Cardiothorac Vasc Anesth 13 2 1999 186 190
81. J.H. Levy, and J.M. Bailey Phosphodiesterase inhibitors: the inotropes of choice for the new millennium? J Cardiothorac Vasc Anesth 14 4 2000 365 366
82. P. Laitinen, J. Ahonen, and K.T. Olkkola Pharmacokinetics of amrinone in neonates and infants J Cardiothorac Vasc Anesth 14 4 2000 378 382
83. M.P. Ross, E.M. Allen-Webb, and J.B. Pappas Amrinone-associated thrombocytopenia: pharmacokinetic analysis Clin Pharmacol Ther 53 6 1993 661 667
84. A.C. Chang, A.M. Atz, and G. Wernovsky Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery Crit Care Med 23 11 1995 1907 1914
85. C. Ramamoorthy, G.D. Anderson, and G.D. Williams Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery Anesth Analg 86 2 1998 283 289
86. T.W. Smith Digitalis: mechanisms of action and clinical use N Engl J Med 318 6 1988 358 365
87. W. Berman Jr, S.M. Yabek, and T. Dillon Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect N Engl J Med 308 7 1983 363 366
88. D. Lang, and G. von Bernuth Serum concentration and serum half-life of digoxin in premature and mature newborns Pediatrics 59 6 1977 902 906
89. E. Steiness Renal tubular secretion of digoxin Circulation 50 1 1974 103 107
90. A.R. Hastreiter, R.L. van der Horst, and C. Voda Maintenance digoxin dosage and steady-state plasma concentration in infants and children J Pediatr 107 1 1985 140 146
91. J.A. Ingelfinger, and P. Goldman The serum digitalis concentration-does it diagnose digitalis toxicity? N Engl J Med 294 16 1976 867 870
92. J. Lindenbaum, D.G. Rund, and V.P. Butler Jr Inactivation of digoxin by the gut flora: reversal by antibiotic therapy N Engl J Med 305 14 1981 789 794
93. S. Waldorff, J.D. Andersen, and N. Heeboll-Nielsen Spironolactone-induced changes in digoxin kinetics Clin Pharmacol Ther 24 2 1978 162 167
94. T.W. Smith, V.P. Butler Jr, and E. Haber Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases N Engl J Med 307 22 1982 1357 1362
95. D.W. Seccombe, M.R. Pudek, and M.F. Whitfield Perinatal changes in a digoxin-like immunoreactive substance Pediatr Res 18 11 1984 1097 1099
96. R. Valdes Jr Endogenous digoxin-immunoactive factor in human subjects Fed Proc 44 12 1985 2800 2805
97. W.R. Mathews, D.W. DuCharme, and J.M. Hamlyn Mass spectral characterization of an endogenous digitalis-like factor from human plasma Hypertension 17 6 Pt 2 1991 930 935
98. R.M. Ward Persistent pulmonary hypertension N.M. Nelson Current therapy in neonatal-perinatal medicine-2 1990 BC Decker Toronto 331 338
99. S.H. Abman, B.A. Chatfield, and S.L. Hall Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth Am J Physiol 259 6 Pt 2 1990 H1921 H1927
100. P.W. Shaul Ontogeny of nitric oxide in the pulmonary vasculature Semin Perinatol 21 5 1997 381 392
101. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 6122 1987 524 526
102. J. McAndrew, R.P. Patel, and H. Jo The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease Semin Perinatol 21 5 1997 351 366
103. R.H. Steinhorn, F.C. Morin 3rd, and J.R. Fineman Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation Semin Perinatol 21 5 1997 393 408
104. H. Christou, I. Adatia, and L.J. Van Marter Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension J Pediatr 130 4 1997 603 611
105. W. Nakajima, A. Ishida, and H. Arai Methaemoglobinaemia after inhalation of nitric oxide in infant with pulmonary hypertension Lancet 350 9083 1997 1002 1003
106. N.N. Finer, and K.J. Barrington Nitric oxide in respiratory failure in the newborn infant Semin Perinatol 21 5 1997 426 440
107. J.P. Kinsella, W.E. Truog, and W.F. Walsh Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn J Pediatr 131 1 Pt 1 1997 55 62
108. J.D. Roberts Jr, J.R. Fineman, and F.C. Morin III Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group N Engl J Med 336 9 1997 605 610
109. D.N. Cornfield, R.C. Maynard, and R.A. deRegnier Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension Pediatrics 104 5 Pt 1 1999 1089 1094
110. N.N. Finer, and K.J. Barrington Nitric oxide for respiratory failure in infants born at or near term Cochrane Database Syst Rev 4 2001 CD000399
111. L.D. Nelin, and G.M. Hoffman The use of inhaled nitric oxide in a wide variety of clinical problems Pediatr Clin N Am 45 3 1998 531 548
112. R.W. Day, J.M. Lynch, and K.S. White Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension Pediatrics 98 4 Pt 1 1996 698 705
113. S. Demirakca, J. Dotsch, and C. Knothe Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning Crit Care Med 24 11 1996 1913 1919
114. P.A. Lonnqvist Inhaled nitric oxide in newborn and paediatric patients with pulmonary hypertension and moderate to severe impaired oxygenation: effects of doses of 3-100 parts per million Intensive Care Med 23 7 1997 773 779
115. T.A. Nakagawa, A. Morris, and R.J. Gomez Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome J Pediatr 131 1 Pt 1 1997 63 69
116. W. Tworetzky, J. Bristow, and P. Moore Inhaled nitric oxide in neonates with persistent pulmonary hypertension Lancet 357 9250 2001 118 120
117. M. Hallman, K. Bry, and R. Turbow Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure J Pediatr 132 5 1998 827 829
118. P.Y. Cheung, E. Salas, and R. Schulz Nitric oxide and platelet function: implications for neonatology Semin Perinatol 21 5 1997 409 417
119. R.H. Clark, J.L. Huckaby, and T.J. Kueser Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up J Perinatol 23 4 2003 300 303
120. R. Desandes, E. Desandes, and P. Droulle Inhaled nitric oxide improves oxygenation in very premature infants with low pulmonary blood flow Acta Paediatr 93 1 2004 66 69
121. T.J. Kulik, and J.E. Lock Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn Clin Perinatol 11 3 1984 693 701
122. R.M. Ward Pharmacology of tolazoline Clin Perinatol 11 3 1984 703 713
123. P. Nuntnarumit, S.B. Korones, and W. Yang Efficacy and safety of tolazoline for treatment of severe hypoxemia in extremely preterm infants Pediatrics 109 5 2002 852 856
124. C. Stocker, D.J. Penny, and C.P. Brizard Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery Intensive Care Med 29 11 2003 1996 2003
125. M. Ehlen, and B. Wiebe Iloprost in persistent pulmonary hypertension of the newborn Cardiol Young 13 4 2003 361 363
126. L.K. Kelly, N.F. Porta, and D.M. Goodman Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide J Pediatr 141 6 2002 830 832